Is KeyCorp (KEY) Going to Burn These Hedge Funds?

Page 1 of 2

KeyCorp (NYSE:KEY) was in 30 hedge funds’ portfolio at the end of the first quarter of 2013. KEY has experienced a decrease in hedge fund interest in recent months. There were 34 hedge funds in our database with KEY positions at the end of the previous quarter.

According to most shareholders, hedge funds are perceived as slow, outdated investment vehicles of years past. While there are greater than 8000 funds in operation today, we at Insider Monkey hone in on the crème de la crème of this group, about 450 funds. It is widely believed that this group oversees the lion’s share of the smart money’s total asset base, and by paying attention to their best equity investments, we have formulated a number of investment strategies that have historically outperformed the market. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 23.3 percentage points in 8 months (explore the details and some picks here).

KeyCorpJust as key, positive insider trading sentiment is another way to break down the world of equities. Obviously, there are a variety of incentives for an upper level exec to downsize shares of his or her company, but just one, very clear reason why they would buy. Several academic studies have demonstrated the useful potential of this method if “monkeys” understand what to do (learn more here).

Keeping this in mind, let’s take a glance at the latest action regarding KeyCorp (NYSE:KEY).

How are hedge funds trading KeyCorp (NYSE:KEY)?

Heading into Q2, a total of 30 of the hedge funds we track were long in this stock, a change of -12% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were upping their holdings meaningfully.

KeyCorp (NYSE:KEY)When looking at the hedgies we track, Martin Whitman’s Third Avenue Management had the most valuable position in KeyCorp (NYSE:KEY), worth close to $211 million, comprising 4.1% of its total 13F portfolio. Coming in second is Cliff Asness of AQR Capital Management, with a $105.2 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Other peers that hold long positions include Richard S. Pzena’s Pzena Investment Management, Jim Simons’s Renaissance Technologies and John Brennan’s Sirios Capital Management.

Judging by the fact that KeyCorp (NYSE:KEY) has experienced bearish sentiment from the smart money, logic holds that there exists a select few hedgies that slashed their positions entirely last quarter. Intriguingly, Phill Gross and Robert Atchinson’s Adage Capital Management sold off the biggest stake of the “upper crust” of funds we monitor, valued at about $20.5 million in stock.. Ken Gray and Steve Walsh’s fund, Bryn Mawr Capital, also sold off its stock, about $11.2 million worth. These transactions are interesting, as aggregate hedge fund interest dropped by 4 funds last quarter.

How have insiders been trading KeyCorp (NYSE:KEY)?

Bullish insider trading is particularly usable when the primary stock in question has experienced transactions within the past 180 days. Over the last half-year time period, KeyCorp (NYSE:KEY) has experienced 1 unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to KeyCorp (NYSE:KEY). These stocks are Canadian Imperial Bank of Commerce (USA) (NYSE:CM), First Republic Bank (NYSE:FRC), SunTrust Banks, Inc. (NYSE:STI) and Credicorp Ltd. (USA) (NYSE:BAP). This group of stocks are in the money center banks industry and their market caps match KEY’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!